Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
Contact: Mark [email protected] WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax: “On behalf…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
WASHINGTON, D.C. – In an op-ed published today in Morning Consult, AdvaMed® President and CEO Scott Whitaker urges Congress to act before the medical device excise tax comes back into effect Jan. 1.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement today from President and CEO Scott Whitaker regarding the U.S. Senate’s confirmation of Dr. Stephen Hahn to…
WASHINGTON, D.C. – In today’s Wall Street Journal, the editorial board wrote that Congress “should stop a return of the destructive” medical device excise tax scheduled to go into effect on Jan.…
WASHINGTON, D.C. – More than half of medical device company employees expect reinstatement of the medical device excise tax in 2020 to lead both to job losses and cuts to research…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Washington, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly upgraded United States-Mexico-Canada Agreement (USMCA):